RVTY

Revvity Inc

• TipRanks·1d ago

  Revvity Rated Buy on Improving Fundamentals and Undervaluation; $120 Price Target Reaffirmed

• Simply Wall St·2d ago

  Revvity (RVTY) Stock Could Be 10.9% Undervalued Despite Profit And Growth Pressure

• Simply Wall St·3d ago

  Are Revvity’s Slowing Organic Gains Quietly Rewriting Its Margin-Led Growth Story (RVTY)?

• Simply Wall St·06/08 17:17

  How Investors May Respond To Revvity (RVTY) Divesting Its China Immunodiagnostics Business

• Seeking Alpha·06/07 13:05

  Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus

• Simply Wall St·06/05 06:24

  A Look At Revvity (RVTY) Valuation After Recent Share Price Momentum And Margin Expansion Narrative

• Seeking Alpha·06/02 14:00

  These 10 large-cap U.S. healthcare companies carry the market's most expensive valuations

• Benzinga·06/02 11:28

  Wolfe Research Assumes Revvity at Peer Perform

• Seeking Alpha·05/31 13:05

  Notable healthcare headlines for the week: UnitedHealthcare, Pfizer, Eli Lilly in focus

• Dow Jones·05/28 20:35

  Revvity Inc. Stock Advances 4.6%, Outperforms Peers

• Simply Wall St·05/28 09:13

  Revvity (RVTY) Valuation Check After Mixed Recent Share Performance

• Seeking Alpha·05/26 08:17

  Stock futures rise on hopes of U.S.-Iran conflict resolution

• Simply Wall St·05/24 23:21

  Is It Time To Reassess Revvity (RVTY) After Its Recent Share Price Rebound?

• Simply Wall St·05/18 09:29

  Revvity (RVTY) Is Down 5.0% After Raising 2026 Outlook And Securing FDA Assay Clearance

• TipRanks·05/14 10:50

  Analysts Conflicted on These Healthcare Names: Cullinan Management (CGEM), Humacyte (HUMA) and Revvity (RVTY)